Africa is home to the most genetically diverse population in the world. Yet just 2% of genetic materials used in pharmaceutical research comes from the continent; 90% comes from Caucasians.   Abasi Ene-Obong is looking to change that with 54gene, the first biobank of…

A sickle-cell drug common to wealthy countries has been deemed safe to use in Africa, home to 75% of babies born with the condition each year. Hydroxyurea is cheap, effective and easily administered against the painful and potentially deadly condition.

While life expectancy has increased for many major illnesses, the same cannot be said for sickle cell disease, which affects 100,000 people in the US, mostly African Americans.   Discrimination in the health care system and limited access to appropriate care prevent people…

A team in a Ghana hospital that focused on treating pregnant women with sickle cell disease reduced death rates by nearly 90%.   Women with sickle cell disease at Korle-Bu Teaching Hospital in Accra were 12 times as likely to die in childbirth as women who didn’t have the…

The American Society of Hematology (ASH) plans to call for a sickle cell moonshot this fall—an all-out effort that has been long in coming.